Corpus ID: 22089701

Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebitic syndrome: LMW-heparin versus standard heparin.

@article{Verardi1988AntithromboticTD,
  title={Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebitic syndrome: LMW-heparin versus standard heparin.},
  author={S. Verardi and A. Ippoliti and G. Pistolese},
  journal={International angiology : a journal of the International Union of Angiology},
  year={1988},
  volume={7 3 Suppl},
  pages={
          33-40
        }
}
Seventy seven patients affected by postphlebitic syndrome (PPS) during acute inflammatory and/or obstructive complications were controlled. Thirty nine patients were treated with a new low molecular weight heparin (Fluxum), 16,000 I.U. AXa/day subcutaneously for 10 days and, subsequently, 8,000 I.U. AXa/day subcutaneously for up to 50 days. Thirty eight patients were treated with 20,000 I.U./day i.v. for 10 days of sodium heparin and, subsequently, with 12,500 I.U./day of calcium heparin by… Expand
Parnaparin: confronto con le altre eparine a basso peso molecolare
Predictive Value of Skin Perfusion Pressure After Endovascular Therapy for Wound Healing in Critical Limb Ischemia
Skin Perfusion Pressure Is a Prognostic Factor in Hemodialysis Patients
...
1
2
...